Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef T Prchal

Showing results (181-190 of 241) with videos related to

Pageof 25
Sort By:
Therapeutic Advances in Hematology|July 30, 2025
Real-world characteristics and treatment patterns in essential thrombocythemia: a population-based cross-sectional study in Taiwan between 2020 and 2021Ming-Sun Yu, Lennex Hsueh-Lin Yu, Shih-Hao Huang, et al.
Neonatology|September 28, 2020
A Novel Variant in G6PD (c.1375C>G) Identified from a Hispanic Neonate with Extreme Hyperbilirubinemia and Low G6PD Enzymatic ActivityTimothy M Bahr, Michell Lozano-Chinga, Archana M Agarwal, et al.
Blood|January 31, 2012
Methylation of AR locus does not always reflect X chromosome inactivation stateSabina I Swierczek, Lucie Piterkova, Jaroslav Jelinek, et al.
British Journal of Haematology|February 18, 2011
Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of ageScott Samuelson, Brenda M Sandmaier, Helen E Heslop, et al.
Haematologica|February 14, 2013
The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W)Nikica Ljubas Tomasic, Lucie Piterkova, Chad Huff, et al.
Experimental Hematology|October 12, 2010
In vitro and in vivo characterization of SGI-1252, a small molecule inhibitor of JAK2Kausar Begam Riaz Ahmed, Steven L Warner, Andrew Chen, et al.
Blood|January 27, 2005
Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasiaDamiano Rondelli, Giovanni Barosi, Andrea Bacigalupo, et al.
Neonatology|September 23, 2015
Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with HemolysisRobert D Christensen, Daniel T Malleske, Diane K Lambert, et al.
Blood|January 17, 2004
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumorsVictor R Gordeuk, Adelina I Sergueeva, Galina Y Miasnikova, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 19, 2010
Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by the NF-κB pathwayHye-Ja Lee, Kyungah Maeng, Hung-The Dang, et al.
Pageof 25

Showing results (181-190 of 241) with videos related to

Sort By:
Pageof 25
Therapeutic Advances in Hematology|July 30, 2025
Real-world characteristics and treatment patterns in essential thrombocythemia: a population-based cross-sectional study in Taiwan between 2020 and 2021Ming-Sun Yu, Lennex Hsueh-Lin Yu, Shih-Hao Huang, et al.
Neonatology|September 28, 2020
A Novel Variant in G6PD (c.1375C>G) Identified from a Hispanic Neonate with Extreme Hyperbilirubinemia and Low G6PD Enzymatic ActivityTimothy M Bahr, Michell Lozano-Chinga, Archana M Agarwal, et al.
Blood|January 31, 2012
Methylation of AR locus does not always reflect X chromosome inactivation stateSabina I Swierczek, Lucie Piterkova, Jaroslav Jelinek, et al.
British Journal of Haematology|February 18, 2011
Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of ageScott Samuelson, Brenda M Sandmaier, Helen E Heslop, et al.
Haematologica|February 14, 2013
The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W)Nikica Ljubas Tomasic, Lucie Piterkova, Chad Huff, et al.
Experimental Hematology|October 12, 2010
In vitro and in vivo characterization of SGI-1252, a small molecule inhibitor of JAK2Kausar Begam Riaz Ahmed, Steven L Warner, Andrew Chen, et al.
Blood|January 27, 2005
Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasiaDamiano Rondelli, Giovanni Barosi, Andrea Bacigalupo, et al.
Neonatology|September 23, 2015
Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with HemolysisRobert D Christensen, Daniel T Malleske, Diane K Lambert, et al.
Blood|January 17, 2004
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumorsVictor R Gordeuk, Adelina I Sergueeva, Galina Y Miasnikova, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 19, 2010
Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by the NF-κB pathwayHye-Ja Lee, Kyungah Maeng, Hung-The Dang, et al.
Pageof 25